Clinical evaluation of monotherapy with cefpirome for infections complicating hematological disorders

Area of Science:

• Infectious Diseases
• Hematology
• Pharmacology

Background:

• Patients with hematological diseases are susceptible to severe infections.
• Neutropenia significantly increases infection risk and complications.
• Empirical antibiotic therapy is crucial in managing these infections.

Purpose of the Study:

• To evaluate the clinical efficacy and benefits of cefpirome (CPR) monotherapy.
• To compare CPR monotherapy with empirical combination antibiotic therapy.
• To assess the impact on patient quality of life and healthcare resource utilization.

Main Methods:

• Prospective evaluation of 38 infected patients with hematological diseases.
• Included patients with acute leukemia, myelodysplastic syndrome, lymphoma, and aplastic anemia.
• Monitored clinical outcomes, infection types (septicemia, pneumonia, fever), and neutropenia status.

Main Results:

• Cefpirome (CPR) monotherapy achieved satisfactory or improved clinical efficacy in 89.5% of patients.
• Compared to combination therapy, CPR monotherapy reduced infusion volume and administration frequency.
• Led to improved quality of life, lower cost-benefit ratio, and reduced nursing workload.

Conclusions:

• Cefpirome (CPR) monotherapy is highly effective for infections in hematological disease patients.
• It offers significant advantages over combination therapy, improving patient well-being.
• Recommended as a front-line treatment, especially for neutropenic patients with hematological malignancies.